. would like to inform the financial results for the first quarter of 2019. The Company and its subsidiary reported a net profit of THB 127.61 million or earnings per share of THB 0.13, comparing to a net
Public Company Limited ("the Company") No. 7/2019 on 13 August 2019, it was resolved to approve the financial statements and the operating results of the Company. For the period ended June 30, 2019, which
the sale of real estate. Profit and Loss Statement Consolidated Financial Statement Comparison of Haft-Yearly Separate Financial statement In(De)crease % 31th Mar 2018 31th Mar 2017 31th Mar 2018 31th
, and (2) the Company recorded the doubtful accounts on long-term loan to joint ventures of 910 million Baht in the same period last year. In Q2 2018, the Company had finance cost of 198 million Baht
Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on operating results and the financial position had varied over 20 percent for Q3/2018 ending on September 30
the company to rectify its financial condition to comply with the net fund maintenance rules as well as solve the issue of its improper and inadequate management and personnel structures and the case
a programme to improve the quantity and quality of environmental disclosures from corporates and financial institutions in Thailand • The provision of data and insights from CDP to the SEC and other
term collaboration with World Bank to further strengthen audit oversight practices in the region.Audits play a crucial role in upholding the reliability of financial statements and investors? confidence
%, compared with the same period of the last year. As a result of operating profit that significant growth and finance costs are very low level because of the stable financial position. DOD BIOTECH PUBLIC
คำอธิบายและการวิเคราะห์ของฝ่ายจัดการ 8 November 2019 Re: To clarify the financial statements as of 30 September 2019 To: President The Stock Exchange of Thailand As WHA Corporation Public Company